31
Mita Takeshi, Furukawa Yuki, Iwasa Motoyoshi, Komoda Mitsuaki: (Ja) イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤, (En) Isoxazoline-substituted benzamide compound and pest control agent. Nissan Chemical, Mita Takeshi, Furukawa Yuki, Iwasa Motoyoshi, Komoda Mitsuaki, HANABUSA Tsuneo, September 12, 2008: WO/2008/108448 (32 worldwide citation)

(EN) Disclosed is a novel pest control agent, particularly an insecticide or a miticide. Specifically disclosed is an isoxazoline-substituted benzamide compound represented by the general formula (1) (which is expressed as [chemical formula 1] in claim 1), or a salt thereof. Also disclosed is a pest ...


32
Ostapoff Roland, Nentwick Brian, Stevenson Richard: Wound closure material. Tyco Healthcare Group, Ostapoff Roland, Nentwick Brian, Stevenson Richard, ARYN Wadadli, September 12, 2008: WO/2008/109123 (32 worldwide citation)

Articles are provided having no orientation or a multi-directional orientation. Such articles may be in the form of films, ribbons, sheets, and/or tapes and may be utilized as buttresses with a surgical stapling apparatus or as reinforcing means for suture lines.


33
Rebuffat Carlo, David Dante: Stapler for mucosectomy. Rebuffat Carlo, David Dante, CONCONE Emanuele, September 12, 2008: WO/2008/107918 (32 worldwide citation)

The head of a stapler for mucosectomy comprises an external goblet-shaped body (1) wherein an internal goblet-shaped body (2) is concentrically and slidingly located, at the edge of which a circular blade (3) is fixed. The internal goblet-shaped body (2) is provided with a central hole (5) wherein a ...


34
Shaviv Hilla: Devices, systems and methods for shortening menstrual period duration. Shaviv Hilla, KOLTON Lihu, September 12, 2008: WO/2008/107902 (30 worldwide citation)

Devices and systems for facilitating the flow of menses through the cervix and for shortening the duration of menstruation include a pressure oscillations generating unit insertable into a vagina and configured for delivering pressure oscillations and/or acoustic waves and/or shock waves to the vagi ...


35
Krafft Philippe, Gilbeau Patrick: Process for the manufacture of dichloropropanol. Solvay, Krafft Philippe, Gilbeau Patrick, VANDE GUCHT Anne, September 12, 2008: WO/2008/107468 (30 worldwide citation)

Process for manufacturing dichloropropanol via reaction between glycerol and/or monochloropropanediol and a chlorinating agent in a reactor which is supplied with one or more liquid streams, in which the sum of the glycerol and monochloropropanediol contents in all the liquid streams introduced into ...


36
Steinberg Eran, Bigioi Petronel, Corcoran Peter, Gangea Mihnea, Petrescu Stefan Mirel, Vasiliu Andrei, Costache Gabriel, Drimbarean Alexandru: Face searching and detection in a digital image acquisition device. Fotonation Vision, Steinberg Eran, Bigioi Petronel, Corcoran Peter, Gangea Mihnea, Petrescu Stefan Mirel, Vasiliu Andrei, Costache Gabriel, Drimbarean Alexandru, CONOR Boyce, September 12, 2008: WO/2008/107002 (30 worldwide citation)

A method of detecting a face in an image includes performing face detection within a first window of the image at a first location. A confidence level is obtained from the face detection indicating a probability of the image including a face at or in the vicinity of the first location. Face detectio ...


37
Ying Jackie Y, Wan Andrew C A, Tai Benjamin: Particles for delivery of bioactive factors. Agency For Science Technology And Research, Ying Jackie Y, Wan Andrew C A, Tai Benjamin, ELLA CHEONG SPRUSON PO Box 1531 ROBINSON ROAD POST OFFICE Singapore 903031, September 12, 2008: WO/2008/108736 (28 worldwide citation)

Provided herein are cell-responsive biodegradable microparticles, comprising a hydrophilic polymer crosslinked with a crosslinking group which is degradable by a releasing species produced by a cell and a binding species coupled to the polymer for binding and delivering a bioactive factor, such as a ...


38
Beltran Pedro J, Calzone Frank J, Friberg Gregory, Haqq Christopher, Tolcher Anthony W: Methods and compositions for treating tumor diseases. Amgen, Beltran Pedro J, Calzone Frank J, Friberg Gregory, Haqq Christopher, Tolcher Anthony W, MACHIN Nathan, September 12, 2008: WO/2008/108986 (27 worldwide citation)

The present invention provides, in part, methods for treating a tumor in a human subject comprising inhibiting IGF-1 receptor signaling, methods of determining whether a tumor is more or less likely to respond to such treatment, and compositions for practicing such methods. In particular embodiments ...


39
Arkenau Maric Elisabeth, Bartholomäus Johannes, Ziegler Iris, Haupts Marcel: (De) Darreichungsform mit erschwertem missbrauch, (En) Pharmaceutical form with impeded abuse. Grünenthal, Arkenau Maric Elisabeth, Bartholomäus Johannes, Ziegler Iris, Haupts Marcel, KUTZENBERGER Helga, September 12, 2008: WO/2008/107149 (26 worldwide citation)

(EN) The present invention relates to a multiparticulate pharmaceutical form with impeded abuse including at least one active ingredient with the potential for abuse (A), at least one synthetic or natural polymer (C), optionally at least one natural, semi-synthetic, or synthetic wax (D), at least on ...


40
Flanagan Aiden, Mcmorrow David, Malone Anthony, O Connor Tim: Medical device with a porous surface for delivery of a therapeutic agent. Boston Scientific, Flanagan Aiden, Mcmorrow David, Malone Anthony, O Connor Tim, STERN Gidon D, September 12, 2008: WO/2008/108987 (26 worldwide citation)

The present invention is generally directed to implantable medical devices for delivering therapeutic agents to the body tissue of a patient and methods for making such medical devices. In particular, the present invention is directed to implantable medical devices, such as intravascular stents, hav ...